Medidata Solutions Inc (MDSO)

75.13
0.35 0.47
NASDAQ : Technology
Prev Close 74.78
Open 74.63
Day Low/High 74.38 / 74.92
52 Wk Low/High 30.22 / 54.99
Volume 9.62K
Avg Volume 709.20K
Exchange NASDAQ
Shares Outstanding 58.50M
Market Cap 4.43B
EPS 0.50
P/E Ratio 128.44
Div & Yield N.A. (N.A)

Latest News

Short Interest In Medidata Solutions Falls 11.4%

Short Interest In Medidata Solutions Falls 11.4%

The most recent short interest data has been released for the 06/30/2017 settlement date, which shows a 482,033 share decrease in total short interest for Medidata Solutions, Inc. , to 3,753,954, a decrease of 11.38% since 06/15/2017.

Medidata Successfully Hosts Annual European NEXT Conference Series

Medidata Successfully Hosts Annual European NEXT Conference Series

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the successful completion of the annual NEXT Conference series in Europe during June...

Worldwide Clinical Trials Selects Medidata To Streamline Clinical Site Reimbursements Across The Globe

Worldwide Clinical Trials Selects Medidata To Streamline Clinical Site Reimbursements Across The Globe

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that after an exhaustive 18 month selection process which encompassed all of the...

Medidata Schedules Second Quarter Earnings Conference Call For July 18, 2017

Medidata Schedules Second Quarter Earnings Conference Call For July 18, 2017

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its second quarter 2017 financial results before the open of the...

Chugai Deploys RaveX To Modernize Post-Marketing Surveillance

Chugai Deploys RaveX To Modernize Post-Marketing Surveillance

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that Chugai Pharmaceutical Co.

Theracos More Effectively Manages Both Data And Content With Medidata's ETMF And ETMF Archive Solutions

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that Theracos has expanded its use of the Medidata Clinical Cloud® to include...

InVentiv Health Selects Medidata Enroll®, Medidata's EConsent Platform, To Accelerate Clinical Trials

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, and inVentiv Health, a leading biopharmaceutical professional services company, today announced...

Median Technologies And Medidata Partner To Deliver Differentiated Image Management Services In Clinical Trials

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, and Median Technologies (Paris:ALMDT), the Imaging Phenomics Company™, today announced a...

Sponsors And CROs Rely On Analytics In Clinical Research But Are Limited To Traditional And In-House Data, Medidata Finds

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced results of an industry survey to better understand how global life sciences companies...

Chiltern And Medidata Mark 10-Year Anniversary Milestone In Bringing Cloud-based Technology To Clinical Development

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, and Chiltern, a leading global contract research organization (CRO), today announced an...

UPDATED PRESENTATION DATE: Medidata To Present At Bank Of America Merrill Lynch 2017 Global Technology Conference

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that Rouven Bergmann, chief financial officer, will present at the Bank of America...

Medidata To Present At Bank Of America Merrill Lynch 2017 Global Technology Conference

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that Rouven Bergmann, chief financial officer, will present at the Bank of America...

Medidata To Present First-of-its-kind Scientific Innovation At 2017 ASCO Annual Meeting

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced its participation in the 2017 American Society of Clinical Oncology (ASCO)...

UPDATED PRESENTATION TIME FOR MAY 22: Medidata To Present At Upcoming Investor Conference

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that the company will present at the following upcoming investor conferences.

Medytox To Further Expand Global Presence By Increasing Its Adoption Of The Medidata Clinical Cloud®

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, announced today that Medytox, a global biopharmaceutical company based in Korea, will expand its use...

Medidata's Julie Iskow Named A "Luminary" By The Healthcare Businesswomen's Association

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that Julie Iskow has been named a 2017 "Luminary" by the Healthcare...

Medidata Introduces Regulated Content And Document Management Capabilities To Its Industry-Leading Cloud Platform

On the heels of its recent acquisition of CHITA, Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the availability of its...

Medidata To Present At Upcoming Investor Conferences

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that the company will present at the following upcoming investor conferences.

Medidata Solutions Stock Sees Short Interest Fall 13.2%

The most recent short interest data has been released for the 04/13/2017 settlement date, which shows a 695,534 share decrease in total short interest for Medidata Solutions, Inc. , to 4,569,602, a decrease of 13.21% since 03/31/2017.

Medidata Reports Record First Quarter 2017 Results

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced its financial results for the first quarter of 2017.

UCB Selects Medidata Clinical Cloud® To Support Patient-Centric Drug Development

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that UCB has selected the Medidata Clinical Cloud ® as its enterprise...

WuXi Clinical Development Services Expands Use Of Medidata's Cloud Technology Platform

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced an expanded partnership with WuXi Clinical Development Services ("WuXi CDS"), a...

Medidata To Acquire Mytrus To Take Next Step In Transforming The Clinical Trial Patient Experience

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that the company has agreed to acquire Mytrus, Incorporated, an e-clinical technology...

Medidata Schedules First Quarter Earnings Conference Call For April 26, 2017

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its first quarter 2017 financial results before the open of the...

Medidata Wins Informa CARE Award For "Clinical Trial Partnership Of The Year"

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that its unique technology collaboration with TESARO, Inc.

Karyopharm And Medidata Expand Clinical Trial Partnership

Medidata (NASDAQ:MDSO) and clinical-stage pharmaceutical company Karyopharm Therapeutics (NASDAQ:KPTI) today announced an expanded partnership to bring novel machine-learning technology and targeted risk-based monitoring...

Medidata's Clinical Technology Platform Selected For Groundbreaking "Beat AML Master Trial"

Medidata, the leading global provider of cloud-based technology and data analytics for clinical research, today announced that The Leukemia & Lymphoma Society (LLS) has selected the Medidata Clinical Cloud ® to...

Medidata And INC Research Expand Technology Partnership

INC Research Holdings, Inc. (NASDAQ:INCR), a leading, global Phase I to IV contract research organization (CRO), and Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics...